NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer
- Conditions
- Pancreatic Adenocarcinoma
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- Angiodynamics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01369420
- Locations
- ๐ฎ๐น
Policlinico "G.B. Rossi", University of Verona, Department of Surgery, Verona, Italy
Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein
- Conditions
- Varicose VeinsVenous Insufficiency
- Interventions
- Device: VenaCure EVLT NeverTouchDevice: VNUS RF ClosureFAST
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2012-07-13
- Lead Sponsor
- Angiodynamics, Inc.
- Registration Number
- NCT01173419
- Locations
- ๐บ๐ธ
UC Davis Interventional and Vascular Radiology, Sacramento, California, United States
๐บ๐ธMidwest Institute for Minimally Invasive Therapies (MIMIT), Melrose Park, Illinois, United States
๐บ๐ธNovi Vein Center, Novi, Michigan, United States
Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)
- Conditions
- Carcinoma, Hepatocellular
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- Angiodynamics, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01078415
- Locations
- ๐ช๐ธ
Barcelona Clinic Liver Cancer Group, Hospital Clinic i Provincial de Barcelona, Barcelona, Spain
๐ซ๐ทHopital Beaujon, Paris, France
๐ฉ๐ชUniversitatsklinikum Magdeburg AoR, Klinik fur Radiologie und Nuklearmedizin, Magdeburg, Germany
Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)
- Conditions
- Acute Kidney InjuryRenal Failure Chronic Contrast InducedChronic Kidney DiseaseAcute Renal Failure
- Interventions
- Device: Benephit catheter for Targeted Renal Therapy
- First Posted Date
- 2010-02-09
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- Angiodynamics, Inc.
- Registration Number
- NCT01064895
- Locations
- ๐บ๐ธ
St. John Hospital & Medical Center, Detroit, Michigan, United States
๐บ๐ธBaptist Cardiac & Vascular Institute, Miami, Florida, United States
๐บ๐ธHealthwoRx South Florida Research Solutions, Miramar, Florida, United States
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation
- Conditions
- Non Small Cell Lung CancerPulmonary Metastases
- Interventions
- Device: RF ablation (Rita Medical Systems Model 1500x)
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2008-06-05
- Lead Sponsor
- Angiodynamics, Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT00690703
- Locations
- ๐บ๐ธ
UCLA Medical Center, Los Angeles, California, United States
๐ฆ๐บUniversity of New South Wales, Sydney, Australia
๐ฉ๐ชUniversity Hospital Essen, Essen, Germany